Sectors

Motif FoodWorks, which traces its roots to MIT, has pocketed $226m in a round backed by returning investor Louis Dreyfus a month after Motif’s parent agreed to a reverse merger.

The marketing platform developer is using cash from the United Internet-backed round to acquire MomentFeed, a deal that will allow Rockfish to exit.

Shell Ventures has re-upped in G2 Venture Partners’ sophomore fund, which was also backed by Mitsui, Daimler and ABB Switzerland.

The Johnson & Johnson, GSK and AstraZeneca-backed drug developer raised the cash in a Patient Square Capital-led round that took its total funding beyond $200m.

The CSP technology developer revealed two new funding rounds including an $83m bridge round backed by ArcelorMittal and Edison International.

GV has participated in a $41.9m series B extension for the birth control delivery service, which increased the round's size to $92.9m.

UCL Technology Fund has participated in a $145m round that will allow Apollo Therapeutics to advance assets into the clinic and open a US office.

Maryland Momentum Fund and VTC Innovation Fund have both contributed to a series A round for Veralox Therapeutics, which is focusing on diseases with unmet needs.

UTokyo IPC has contributed to a funding round for Telexistence that brought the remote-controlled robotics technology developer’s total funding to $41m.

Tom Arnost had worked on merger and acquisition deals for Verizon before formally joining the corporate’s VC subsidiary last month.

Bitwise Asset Management completed a $70m round backed by Coinbase at a $500m-plus valuation, while luxury goods wholesaler Joor raised $46m to take its overall funding to $81m.